Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

PBT-434 prevents nigral cell death in models of Parkinson's disease

Oct. 14, 2010

Phase I/II trials suggest efficacy of Neuvax vaccine in prevention of breast cancer recurrence

Oct. 13, 2010

Pfizer introduces new candidates for inhalation therapy of COPD

Oct. 13, 2010

First-in-human data disclosed on NIBR-6465

Oct. 13, 2010

Snapshots: Recent data on the antibacterial activity of CXA-101

Oct. 13, 2010

Pfizer's antibacterial MC-1 shows promising preclinical activity

Oct. 13, 2010

DC-based TaReNef AIDS vaccine is safe and immunogenic in phase I/II trial

Oct. 13, 2010

AGI-101 improves postsurgery survival in high-risk melanoma

Oct. 11, 2010

Tasocitinib meets primary endpoint in phase II psoriasis trial

Oct. 11, 2010

PP-9706642 shows promise as a prophylactic/therapeutic agent for HSV-2 infection

Oct. 11, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...